Related Experiment Video
Updated: Aug 14, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Digitalis in heart failure! Still applicable?
1Department of Internal Medicine III, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany. uta.hoppe@uni-koeln.de
Insights
Cardiac glycosides, like digitalis, can help heart failure patients with sinus rhythm. Low serum concentrations are key for benefits, with no sex-based differences in effectiveness, making them a viable option regardless of gender.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Cardiac glycosides are used for heart failure with atrial fibrillation to control ventricular rate.
- The use of digitalis in systolic heart failure with sinus rhythm remains debated, with concerns about increased mortality in women.
Purpose of the Study:
- To evaluate the effectiveness and safety of cardiac glycosides in patients with heart failure and sinus rhythm.
- To investigate potential sex-based differences in cardiac glycoside effectiveness.
- To determine optimal serum digoxin concentrations for therapeutic benefit.
Main Methods:
- Retrospective analysis of patient data.
- Examination of cardiac glycoside effectiveness and mortality rates.
- Assessment of serum digoxin concentrations and their correlation with outcomes.
Main Results:
- Retrospective analyses show no sex-based differences in cardiac glycoside effectiveness.
- Beneficial effects are linked to low serum digoxin concentrations (0.5-0.8 ng/ml), associated with attenuated sympathetic activation.
- High serum levels correlate with increased mortality.
Conclusions:
- Cardiac glycosides should be considered for symptomatic heart failure patients with sinus rhythm, even with optimal ACE inhibitor, beta-blocker, and diuretic therapy.
- Therapy should aim for low target serum digoxin concentrations (0.5-0.8 ng/ml) irrespective of patient gender.
- Digitalis offers benefits through neurohumoral modulation at therapeutic concentrations.
Abstract:
In patients with heart failure and atrial fibrillation cardiac glycosides, generally in combination with beta-blockers, are indicated to control ventricular rate. In systolic heart failure and sinus rhythm, however, the use of digitalis continues to be debated. There are special concerns that cardiac glycosides might lead to an increased mortality rate in women. Retrospective analyses, however, do not indicate any sex-based differences in the effectiveness of cardiac glycosides. Beneficial effects of cardiac glycosides in heart failure seem to be related to the attenuation of sympathetic activation and neurohumoral alterations, which is already obtained at low digoxin serum concentrations, while high serum levels are associated with increased mortality. Therefore, in patients with sinus rhythm who remain symptomatic under an optimized therapy with ACE inhibitors, beta-blockers and diuretics in addition to digitalis should be considered regardless of the gender. However, target serum digoxin concentrations should be low in a range of 0.5 to 0.8 ng/ml.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

